<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Airway management in acute severe asthma for emergency medicine and critical care</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Airway management in acute severe asthma for emergency medicine and critical care</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Airway management in acute severe asthma for emergency medicine and critical care</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andy Jagoda, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rachel Sullivan, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ron M Walls, MD, FRCPC, FAAEM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Torrey, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Most patients with a severe asthma exacerbation can be managed successfully with aggressive use of beta-agonists, anticholinergics, glucocorticoids, and other medications. Infrequently, such medical interventions are insufficient to reverse the immediate course of disease and endotracheal intubation is required.</p><p>The medications and techniques used to perform advanced airway management, particularly endotracheal intubation, in the patient with a severe asthma exacerbation will be reviewed here. An algorithm for the management of asthma exacerbations in adults is provided  (<a class="graphic graphic_algorithm graphicRef111835" href="/z/d/graphic/111835.html" rel="external">algorithm 1</a>). Other aspects of the diagnosis and management of severe asthma and of emergency airway management are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Medical management of severe asthma in adults (see  <a class="medical medical_review" href="/z/d/html/528.html" rel="external">"Acute exacerbations of asthma in adults: Home and office management"</a> and  <a class="medical medical_review" href="/z/d/html/547.html" rel="external">"An overview of asthma management"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management of mechanical ventilation in patients with asthma (see  <a class="medical medical_review" href="/z/d/html/570.html" rel="external">"Invasive mechanical ventilation in adults with acute exacerbations of asthma"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management of severe asthma in children, including mechanical ventilation (see  <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation of severe asthma (see  <a class="medical medical_review" href="/z/d/html/564.html" rel="external">"Evaluation of severe asthma in adolescents and adults"</a> and  <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assessment and management of the difficult airway and the performance of rapid sequence intubation (See  <a class="medical medical_review" href="/z/d/html/275.html" rel="external">"Approach to the difficult airway in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">PATHOPHYSIOLOGY OF SEVERE ASTHMA</span><span class="headingEndMark"> — </span>Severe asthma exacerbations have several important pathophysiologic effects. Among the most important are:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased work of breathing from severe airflow resistance due to bronchial mucosal inflammation and edema, constriction of bronchial smooth muscle, and mucus in the bronchial lumen</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased intrathoracic pressure from air trapping, which further increases the work of breathing, decreases preload, and increases afterload</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Depletion of catecholamines during prolonged exacerbations</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dehydration through insensible losses (more important in children)</p><p></p><p>The pathophysiology of asthma is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/522.html" rel="external">"Pathogenesis of asthma"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">THE DECISION TO INTUBATE</span><span class="headingEndMark"> — </span>The decision to intubate is a clinical one. A patient with an asthma exacerbation in obvious respiratory distress that the clinician judges to be unsustainable requires prompt intubation. Beyond that, there are no studies or consensus guidelines that predict precisely when intubation is necessary for an asthma exacerbation.</p><p>The clinical assessment that a patient in respiratory distress requires intubation involves the patient's appearance, vital signs including oxygen saturation, and the response to therapy. As an example, the patient who is clearly tiring, speaking only in one- or two-word phrases, and demonstrating either increased distress or declining mental status should be intubated prior to the inevitable respiratory arrest of which these findings warn. It is a combination of the severity of bronchoconstriction and the exhaustion of the patient trying to overcome it that sets the stage for respiratory arrest. When the clinician decides that respiratory failure is advanced, progressing, and unlikely to be reversed by further pharmacologic therapy, intubation should be performed expeditiously, before crisis ensues.</p><p>Unlike other conditions in which intubation essentially "solves the problem," the dynamic hyperinflation potentially caused or exacerbated by mechanical ventilation for a severe asthma exacerbation can have devastating consequences, including cardiovascular collapse and barotrauma. Therefore, intubation of a patient with acute status asthmaticus should be undertaken only when judged clinically necessary. (See  <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/570.html" rel="external">"Invasive mechanical ventilation in adults with acute exacerbations of asthma", section on 'Adverse effects of dynamic hyperinflation'</a>.)</p><p>In most patients (including those with asthma), a simple assessment consisting of three clinical evaluations distinguishes those who require intubation:</p><p class="bulletIndent1"><span class="glyph">●</span>Is there failure of airway maintenance or protection?</p><p class="bulletIndent1"><span class="glyph">●</span>Is there failure of oxygenation or ventilation?</p><p class="bulletIndent1"><span class="glyph">●</span>Is deterioration, particularly of the airway, anticipated? (ie, what is the expected clinical course?)</p><p></p><p>This general approach to emergency intubation is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/268.html" rel="external">"The decision to intubate"</a> and  <a class="medical medical_review" href="/z/d/html/6316.html" rel="external">"Technique of emergency endotracheal intubation in children", section on 'Indications'</a>.)</p><p>In the patient with severe acute asthma, the most important indication for intubation is anticipation of the patient's continued deterioration. Without prompt intervention this can lead to severe hypoxemia or respiratory arrest. Irreversible failure of oxygenation or clinical suspicion of ventilatory failure may also develop, prompting emergent intubation.</p><p>Clinical findings that portend imminent respiratory arrest in a patient with an asthma exacerbation may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Inability to maintain respiratory effort (ie, extreme fatigue)</p><p class="bulletIndent1"><span class="glyph">●</span>Depressed mental status</p><p class="bulletIndent1"><span class="glyph">●</span>Cyanosis</p><p></p><p>Note that these findings are not sensitive indicators of severe attacks; many patients with severe airway obstruction will not manifest these signs. </p><p>Signs associated with a severe asthma exacerbation may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Accessory muscle use; chest wall retractions</p><p class="bulletIndent1"><span class="glyph">●</span>Brief, fragmented speech</p><p class="bulletIndent1"><span class="glyph">●</span>Inability to lie supine</p><p class="bulletIndent1"><span class="glyph">●</span>Profound diaphoresis</p><p class="bulletIndent1"><span class="glyph">●</span>Agitation</p><p class="bulletIndent1"><span class="glyph">●</span>Rapid, shallow breathing (respiratory rate &gt;25 to 30 breaths/minute)</p><p></p><p>Although a peak expiratory flow rate (PEFR) or forced expiratory volume in one second (FEV1) less than 40 percent of predicted (less than 200 L/minute in all but the smallest adolescent and adults or based upon height in children over six years of age  (<a class="graphic graphic_table graphicRef64420" href="/z/d/graphic/64420.html" rel="external">table 1</a>)) indicates severe disease, such evaluations are often difficult to obtain, highly variable, and unreliable in patients with severe asthma exacerbations. Arterial blood gases are also rarely helpful in determining the need for intubation in the emergency setting. End-tidal carbon dioxide (EtCO<sub>2</sub>) monitoring is noninvasive and provides additional evidence of worsening respiratory function and airway obstruction, and correlates with FEV1 and the partial pressure of carbon dioxide (pCO<sub>2</sub>) concentrations obtained by blood gas [<a href="#rid1">1,2</a>]. (See  <a class="medical medical_review" href="/z/d/html/273.html" rel="external">"Carbon dioxide monitoring (capnography)", section on 'Acute respiratory distress'</a>.)</p><p>Patients with asthma with coronavirus disease 2019 (COVID-19) are more likely to be intubated and likely to be ventilated longer compared with patients without asthma, particularly those who are younger and obese. Despite this, the overall mortality is unchanged in patients with asthma when adjusting for comorbidities. In general, clinicians should try to maintain a higher threshold for intubation in patients with severe asthma with coexisting COVID-19 [<a href="#rid3">3-5</a>]. (See  <a class="medical medical_review" href="/z/d/html/5740.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Emergency department management", section on 'Advice related to Covid-19 pandemic'</a>.)</p><p class="headingAnchor" id="H672542719"><span class="h1">RESPIRATORY THERAPIES FOR PATIENTS NOT REQUIRING IMMEDIATE INTUBATION</span><span class="headingEndMark"> — </span>In addition to the administration of bronchodilators and other medical therapies, several respiratory treatments can be used in a patient suffering from a severe, acute asthma exacerbation but who is not on the brink of respiratory failure.</p><p class="headingAnchor" id="H4"><span class="h2">Noninvasive positive pressure ventilation</span><span class="headingEndMark"> — </span>Endotracheal intubation and mechanical ventilation can lead to severe complications in patients with asthma. One possible alternative in patients who are not on the brink of respiratory failure and do not have other contraindications is noninvasive positive pressure ventilation (NPPV) using bilevel positive airway pressure (BLPAP). BLPAP offers positive airway pressure on inspiration and a lower level of continuous positive airway pressure on expiration.</p><p>In some patients with severe respiratory distress, NPPV reduces the work of breathing, decreases airway resistance and the feeling of dyspnea, re-expands collapsed alveoli, and provides rest for the thoracic muscles of respiration. Although evidence is limited, NPPV may reduce the need for invasive mechanical ventilation in patients with asthma. Therefore, a trial of BLPAP prior to invasive mechanical ventilation is reasonable in patients experiencing a severe, persistent exacerbation despite maximal bronchodilator therapy, if they do not already require immediate intubation [<a href="#rid6">6,7</a>]. NPPV is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Noninvasive positive pressure ventilation'</a> and  <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications"</a> and  <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications", section on 'Asthma exacerbation'</a>.)</p><p class="headingAnchor" id="H2716147566"><span class="h2">Heliox</span><span class="headingEndMark"> — </span>Heliox may help a patient with a severe asthma exacerbation who needs time to respond to conventional therapy. Heliox has a lower density than oxygen, causing decreased airway resistance and a consequent reduction in the work of breathing. Heliox has been shown to improve respiratory distress and decrease hospital admissions in patients with severe asthma exacerbations [<a href="#rid8">8,9</a>]. It generally comes in a ratio of 70:30 or 80:20 percent helium to oxygen. Heliox has demonstrated greatest benefit for improving symptoms when used as a nebulizing gas for a beta-2 agonist medication [<a href="#rid9">9</a>]. Benefit is generally seen within minutes after the initiation of therapy. The role of heliox in treating severe asthma is reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/119093.html" rel="external">"Acute exacerbations of asthma in adults: Emergency department and inpatient management", section on 'Helium-oxygen'</a> and  <a class="medical medical_review" href="/z/d/html/541.html" rel="external">"Physiology and clinical use of heliox"</a> and  <a class="medical medical_review" href="/z/d/html/5740.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Emergency department management", section on 'Heliox'</a>.)</p><p class="headingAnchor" id="H479425368"><span class="h2">Oxygen by high flow nasal canula</span><span class="headingEndMark"> — </span>Oxygen delivered via high-flow nasal cannula (HFNC) can be helpful for patients in severe respiratory distress, particularly those who are alert but hypoxemic and expected to respond to conventional therapy. HFNC provides continuous warmed and humidified oxygen, decreases inspiratory resistance, and reduces the work of breathing. Flows of up to 60 L/minute can wash out carbon dioxide and decrease anatomic dead space. In addition, HFNC may produce positive end-expiratory pressure (PEEP) and increase end-expiratory lung volume. The results of several clinical trials suggest that HFNC reduces respiratory distress early in the treatment of moderate to severe asthma [<a href="#rid10">10</a>] and reduces the need for intubation in children [<a href="#rid11">11,12</a>]. (See  <a class="medical medical_review" href="/z/d/html/5747.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Intensive care unit management", section on 'Preintubation therapies'</a> and  <a class="medical medical_review" href="/z/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications"</a>.)</p><p>If intubation is necessary, HFNC can improve preoxygenation and decrease the risk of early desaturation. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care", section on 'Preoxygenation'</a> and  <a class="medical medical_review" href="/z/d/html/114077.html" rel="external">"Heated and humidified high-flow nasal oxygen in adults: Practical considerations and potential applications"</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">RAPID SEQUENCE INTUBATION</span></p><p class="headingAnchor" id="H6"><span class="h2">Approach</span><span class="headingEndMark"> — </span>A patient with a severe asthma exacerbation who is in need of endotracheal intubation is often exhausted with little physiologic reserve and at high risk of sustaining a rapid decline in oxygen saturation and blood pressure after receiving sedating medications and neuromuscular blocking agents. For these reasons, it is important to plan for and achieve intubation as early as possible once the determination has been made that intubation is necessary. Rapid sequence intubation (RSI) is the preferred approach in such cases because it is the most rapid method for securing the airway with the highest likelihood of success [<a href="#rid13">13</a>].</p><p>Aspects of RSI of special relevance to patients with severe asthma are discussed below. The general performance of RSI is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Preoxygenation</span><span class="headingEndMark"> — </span>Achieving adequate preoxygenation in a patient experiencing a severe asthma exacerbation is extremely difficult, if not impossible, due to their high residual volume and functional residual capacity [<a href="#rid14">14</a>]. The clinician must anticipate rapid oxygen desaturation when performing RSI in such patients, despite maximal efforts at preoxygenation. Patients who do not achieve a SpO<sub>2</sub> above 93 percent have a much faster rate of SpO<sub>2</sub> decline during intubation attempts [<a href="#rid15">15</a>]. General measures to improve preoxygenation, including oxygen delivered by high-flow nasal cannula, are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care", section on 'Preoxygenation'</a>.)</p><p>If the patient will tolerate it, preoxygenation via active breathing through a bag valve mask provides significantly higher inspiratory oxygen concentrations than a typical nonrebreather mask. The use of noninvasive positive pressure ventilation may also improve preoxygenation, even if it does not successfully reverse the patient's respiratory failure. (See <a class="local">'Noninvasive positive pressure ventilation'</a> above.)</p><p>Many patients with status asthmaticus require positive pressure ventilation either before or between attempts at intubation. Such ventilation should be delivered by bag and mask using a small tidal volume and high inspiratory flow rate with a prolonged expiratory phase, mimicking the approach used during mechanical ventilation. If a normal tidal volume is delivered at a normal rate, breath stacking and increasing auto-positive end-expiratory pressure (PEEP) may lead to further declines in oxygenation and impair the ability to ventilate the patient. (See  <a class="medical medical_review" href="/z/d/html/570.html" rel="external">"Invasive mechanical ventilation in adults with acute exacerbations of asthma"</a> and  <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Ventilator settings'</a> and  <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Ventilation strategy'</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Positioning and ETT placement</span><span class="headingEndMark"> — </span>Medications for RSI should be administered to the patient while they maintain the position of greatest comfort, which is generally sitting upright. Once the patient loses consciousness, place the patient in a supine position and perform laryngoscopy and intubation.</p><p>Placement of a large endotracheal tube (8 to 9 mm) is desirable in order to minimize airway resistance and facilitate aggressive pulmonary toilet during mechanical ventilation in adults, but tube size should be selected to achieve the most rapid possible intubation [<a href="#rid16">16</a>]. If necessary, the tube can be changed later to one of a larger diameter.</p><p>In children between one and eight years of age, the tube size can be calculated based upon age  (<a class="graphic graphic_table graphicRef72932" href="/z/d/graphic/72932.html" rel="external">table 2</a>) (<a class="calc calc_professional" href="/z/d/html/15651.html" rel="external">calculator 1</a>). A cuffed endotracheal tube is preferable for all age groups and a cuff pressure should be measured, especially in pediatric patients. Older children and adolescents should have the largest possible tube placed (up to 9 mm internal diameter).</p><p>Although cricoid pressure is now considered optional during RSI, it may reduce the flow of air into the stomach should bag-mask ventilation be necessary, particularly given the increased airway resistance from a severe asthma exacerbation.</p><p class="headingAnchor" id="H9"><span class="h2">Pretreatment</span><span class="headingEndMark"> — </span>Pretreatment should be viewed as a supplementary but nonessential step in RSI. A detailed discussion of RSI pretreatment for reactive airway disease is found separately. (See  <a class="medical medical_review" href="/z/d/html/282.html" rel="external">"Pretreatment medications for rapid sequence intubation in adults for emergency medicine and critical care", section on 'Asthma (elevated airway resistance)'</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Choice of induction agent</span><span class="headingEndMark"> — </span>Studies suggest that <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> and <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> have bronchodilatory properties and thus are suitable induction agents in a patient with a severe asthma exacerbation [<a href="#rid13">13</a>]. Ketamine is preferable because it aids bronchodilation through both direct and indirect mechanisms and helps to maintain blood pressure. Barbiturates, such as thiopental, should be avoided because they can exacerbate bronchospasm through histamine release.</p><p><a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">Ketamine</a> is a dissociative anesthetic that provides several benefits for a patient with a severe asthma exacerbation. It acts directly as a smooth muscle dilator, increases circulating catecholamines (thus indirectly dilating smooth muscle), inhibits vagal outflow, decreases production of vasodilatory nitric oxide, and does not cause histamine release. Ketamine is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care", section on 'Ketamine'</a> and  <a class="medical medical_review" href="/z/d/html/113029.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Medications for sedation and paralysis", section on 'Ketamine'</a>.)</p><p>Large, randomized trials to assess the effectiveness of <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> in the intubation of patients with asthma are lacking. A systematic review of ketamine for children with severe asthma found that ketamine decreased respiratory rate and increased peak expiratory flow and oxygen saturation; adverse effects included increased tracheobronchial secretions and hallucinations that seemed to be dose dependent [<a href="#rid17">17</a>]. A number of studies and case reports suggest that ketamine improves pulmonary function and is of benefit in severe asthma [<a href="#rid18">18-21</a>]. In addition, multiple case series suggest that infusions of ketamine improve pulmonary function in patients with severe asthma.</p><p>Not all studies of <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> have been favorable [<a href="#rid22">22-24</a>]. One randomized, placebo-controlled trial of IV ketamine (0.2 mg/kg bolus followed by an infusion of 0.5 mg/kg per hour) in 53 consecutive nonintubated adults with acute asthma failed to demonstrate benefit [<a href="#rid23">23</a>]. However, the rate of dysphoric reactions, a well-known side effect of ketamine, led the investigators to reduce the initial bolus to 0.1 mg/kg after the first nine patients. In another randomized controlled trial of 68 nonintubated children, IV ketamine showed no benefit compared with placebo in ameliorating severe acute asthma exacerbations during the two-hour infusion period [<a href="#rid22">22</a>]. </p><p>The use of anticholinergic premedication (eg, <a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">glycopyrrolate</a>, <a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">atropine</a>) for <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> induction is not routinely necessary. Even though anticholinergic agents may decrease secretions from ketamine, a consortium study found that the use of these agents during pediatric sedation increased the risk of serious adverse events such as laryngospasm and aspiration [<a href="#rid25">25</a>]. If an anticholinergic agent is felt to be required, we prefer atropine since it is associated with less vomiting and fewer airway and respiratory adverse events during pediatric sedation [<a href="#rid26">26</a>]. The evidence is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/113029.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Medications for sedation and paralysis", section on 'Ketamine'</a> and  <a class="medical medical_review" href="/z/d/html/82857.html" rel="external">"Pediatric procedural sedation: Pharmacologic agents", section on 'Ketamine'</a>.)</p><p>Observational studies suggest that <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> has bronchodilatory effects and is therefore a suitable induction agent in the patient with severe asthma [<a href="#rid27">27,28</a>]. However, propofol can cause hypotension, so it is less ideal than <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> in these patients, who are predisposed to drop their blood pressure after intubation. There is no high-quality evidence assessing propofol's role in the emergency intubation of patients with severe asthma. (See  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care", section on 'Propofol'</a>.)</p><p>Ketofol (<a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a>/<a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> admixture) has been associated with favorable hemodynamics during intubation and is a reasonable alternative for induction, although few data involving emergency intubation of patients with asthma are available. Ideal ratios appear to be ketamine:propofol 1:3 or 1:4 [<a href="#rid29">29</a>]. </p><p class="headingAnchor" id="H1613474313"><span class="h2">Rapid sequence intubation in a patient with asthma</span><span class="headingEndMark"> — </span>RSI for a patient with asthma includes induction with 1 to 1.5 mg/kg IV <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> (preferred drug) or 2 mg/kg IV <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> over two minutes. This is followed immediately by 1.5 to 2 mg/kg <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> given by IV push [<a href="#rid30">30</a>]. In patients with contraindications to succinylcholine (eg, hyperkalemia, neuromuscular disease, rhabdomyolysis, or burn or stroke over 72 hours old), <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">rocuronium</a> 1.2 to 1.5 mg/kg IV is used. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">POST-INTUBATION MANAGEMENT</span><span class="headingEndMark"> — </span>Mechanical ventilation in a patient with severe asthma can be difficult to manage and is fraught with potential complications, including cardiovascular collapse and barotrauma. Minimizing airway pressures while maintaining adequate oxygenation is the primary goal of management. Mechanical ventilation in patients with asthma exacerbations is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/570.html" rel="external">"Invasive mechanical ventilation in adults with acute exacerbations of asthma"</a> and  <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Endotracheal intubation and mechanical ventilation'</a>.)</p><p>An intubated patient with an asthma exacerbation is usually hypercapnic with a severe acidosis from the elevated partial pressure of carbon dioxide (pCO<sub>2</sub>) and lactic acidosis, due to their increased work of breathing and beta-agonist use. To avoid subsequent tachypnea and loss of synchronization with the ventilator, patients should be deeply sedated and receive parenteral opioid analgesia with a non-histamine releasing opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) in order to achieve complete relaxation and comfort for mechanical ventilation. Whenever possible, sedation and pain scores should be used to determine whether treatment is adequate. In a few instances, neuromuscular blockade may be required to optimize treatment of patients with severe disease. In addition, minimizing hyperinflation by reducing minute ventilation, lengthening expiration time, and using a low level of positive end-expiratory pressure (PEEP) is recommended. (See  <a class="medical medical_review" href="/z/d/html/277.html" rel="external">"Mechanical ventilation of adults in the emergency department", section on 'Sedation and analgesia for the ventilated patient'</a> and  <a class="medical medical_review" href="/z/d/html/1606.html" rel="external">"Sedative-analgesia in ventilated adults: Management strategies, agent selection, monitoring, and withdrawal"</a> and  <a class="medical medical_review" href="/z/d/html/1590.html" rel="external">"Neuromuscular blocking agents in critically ill patients: Use, agent selection, administration, and adverse effects"</a>.)</p><p>Pharmacologic management of severe asthma exacerbations, which includes short-acting beta-2-selective adrenergic agonists and systemic glucocorticoids, is discussed separately. Use of nonstandard therapies for severe and refractory airflow obstruction, such as biologic agents that target specific pathways in inflammation (eg, IL-5 and IgE), has been described [<a href="#rid31">31,32</a>]; these therapies and agents are also discussed separately. (See  <a class="medical medical_review" href="/z/d/html/119093.html" rel="external">"Acute exacerbations of asthma in adults: Emergency department and inpatient management", section on 'Emergency department management'</a> and  <a class="medical medical_review" href="/z/d/html/5740.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Emergency department management", section on 'Elements of treatment'</a> and  <a class="medical medical_review" href="/z/d/html/551.html" rel="external">"Treatment of severe asthma in adolescents and adults", section on 'Persistently uncontrolled asthma'</a> and  <a class="medical medical_review" href="/z/d/html/119093.html" rel="external">"Acute exacerbations of asthma in adults: Emergency department and inpatient management", section on 'Nonstandard therapies'</a>.)</p><p>The management of acute hypoxemia (such as from pneumothorax, air trapping, mucus plugging, atelectasis, or pneumonia) in an intubated patient with an asthma exacerbation is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/570.html" rel="external">"Invasive mechanical ventilation in adults with acute exacerbations of asthma", section on 'Troubleshooting hypoxemia'</a> and  <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Complications'</a>.)</p><p>In a patient with a severe asthma exacerbation complicated by refractory respiratory acidosis, severe hypoxemia, or hemodynamic instability in the setting of maximal medical management and ventilation settings (ie, "near-fatal" asthma), oxygenation and carbon dioxide removal through an artificial membrane (extracorporeal life support [ECLS]) may be beneficial as a temporizing measure. Use of extracorporeal membrane oxygenation (ECMO) or extracorporeal CO<sub>2</sub> removal (ECCO<sub>2</sub>R) for severe asthma has been associated with good outcomes, reduced mortality, and less ventilator-associated lung injury [<a href="#rid33">33,34</a>]. For example, in a retrospective study of 24 patients with near-fatal asthma who were started on ECLS, 83 percent survived to hospital discharge [<a href="#rid35">35</a>]. Survival with ECLS following cardiac arrest from asthma has also been reported [<a href="#rid36">36</a>]. ECLS is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: Overview"</a> and  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)"</a> and  <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Extracorporeal membrane oxygenation'</a>.)</p><p class="headingAnchor" id="H2032226317"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/127884.html" rel="external">"Society guideline links: Airway management in adults"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Decision to intubate</strong> – The decision to intubate a patient with a severe asthma exacerbation is a clinical one and can be difficult. Patients in obvious respiratory distress that the clinician judges to be unsustainable require prompt intubation. (See <a class="local">'the decision to intubate'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Signs of respiratory distress</strong> – Signs of respiratory distress in a patient with an asthma exacerbation may include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inability to maintain respiratory effort (ie, extreme fatigue)</p><p class="bulletIndent2"><span class="glyph">•</span>Depressed mental status</p><p class="bulletIndent2"><span class="glyph">•</span>Cyanosis</p><p class="bulletIndent2"><span class="glyph">•</span>Accessory muscle use; chest wall retractions</p><p class="bulletIndent2"><span class="glyph">•</span>Brief, fragmented speech</p><p class="bulletIndent2"><span class="glyph">•</span>Inability to lie supine</p><p class="bulletIndent2"><span class="glyph">•</span>Profound diaphoresis</p><p class="bulletIndent2"><span class="glyph">•</span>Agitation</p><p class="bulletIndent2"><span class="glyph">•</span>Rapid, shallow breathing (respiratory rate &gt;25 to 30 breaths/minute)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Potential dangers of mechanical ventilation</strong> – Following intubation, the dynamic hyperinflation potentially caused or exacerbated by mechanical ventilation of in a severe asthma exacerbation can have devastating consequences, including cardiovascular collapse and barotrauma. Intubation and mechanical ventilation must be managed with great care.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatments for patients not at immediate risk of respiratory failure</strong> – Treatments that may help a patient with a severe, acute asthma exacerbation but <strong>not</strong> on the brink of respiratory failure include noninvasive positive pressure ventilation (NPPV), helium-oxygen (heliox) gas, and oxygen delivered by high-flow nasal cannula. (See <a class="local">'Respiratory therapies for patients not requiring immediate intubation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rapid sequence intubation</strong> – Rapid sequence intubation (RSI) is the preferred approach for securing the airway. A patient with severe asthma in need of tracheal intubation has little physiologic reserve and is at high risk of sustaining a rapid decline in oxygen saturation and blood pressure after receiving sedating medications and neuromuscular blocking agents. Therefore, it is important to maximize preoxygenation, achieve intubation expeditiously, and be prepared for oxygen desaturation or hypotension immediately following RSI. (See  <a class="medical medical_review" href="/z/d/html/275.html" rel="external">"Approach to the difficult airway in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Preoxygenation</strong> – Achieving adequate preoxygenation in a patient experiencing a severe asthma exacerbation can be extremely difficult. Many patients with severe acute asthma require positive pressure ventilation either before or between attempts at intubation. Such ventilation should be delivered by bag and mask using a small tidal volume and high inspiratory flow rate with a prolonged expiratory phase. (See <a class="local">'Preoxygenation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">Ketamine</a><strong> is preferred induction agent</strong> – We suggest that ketamine (1 to 2 mg/kg IV) be used as the induction agent for RSI in patients with severe asthma (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Ketamine aids bronchodilation and helps to maintain blood pressure. <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">Propofol</a> can be used and possesses bronchodilatory effects but can cause hypotension. (See <a class="local">'Choice of induction agent'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mechanical ventilation</strong> – Mechanical ventilation in a patient with severe asthma is fraught with potential complications, including cardiovascular collapse and barotrauma. Minimizing airway pressures while maintaining adequate oxygenation is the primary goal of management. Mechanical ventilation in patients with severe asthma exacerbations is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/570.html" rel="external">"Invasive mechanical ventilation in adults with acute exacerbations of asthma"</a> and  <a class="medical medical_review" href="/z/d/html/97585.html" rel="external">"Acute severe asthma exacerbations in children younger than 12 years: Endotracheal intubation and mechanical ventilation", section on 'Endotracheal intubation and mechanical ventilation'</a>.)</p><p></p><p class="headingAnchor" id="H1368022558"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Peter Shearer, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Pertzov B, Ronen M, Rosengarten D, et al. Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients. Respir Res 2021; 22:154.</a></li><li><a class="nounderline abstract_t">Truchot J, Gayet AR, Philippon AL, et al. End tidal carbon dioxide monitoring in acute asthma: a prospective pilot study in emergency department patients. Eur J Emerg Med 2019; 26:412.</a></li><li><a class="nounderline abstract_t">Mahdavinia M, Foster KJ, Jauregui E, et al. Asthma prolongs intubation in COVID-19. J Allergy Clin Immunol Pract 2020; 8:2388.</a></li><li><a class="nounderline abstract_t">Hussein MH, Toraih EA, Attia AS, et al. Asthma in COVID-19 patients: An extra chain fitting around the neck? Respir Med 2020; 175:106205.</a></li><li><a class="nounderline abstract_t">Hussein MH, Elshazli RM, Attia AS, et al. Asthma and COVID-19; different entities, same outcome: a meta-analysis of 107,983 patients. J Asthma 2022; 59:851.</a></li><li><a class="nounderline abstract_t">Althoff MD, Holguin F, Yang F, et al. Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations. Am J Respir Crit Care Med 2020; 202:1520.</a></li><li><a class="nounderline abstract_t">Joshi N, Estes MK, Shipley K, Lee HD. Noninvasive Ventilation For Patients In Acute Respiratory Distress: An Update. Emerg Med Pract 2017; 19:1.</a></li><li><a class="nounderline abstract_t">Castro-Rodriguez JA, J Rodrigo G, E Rodríguez-Martínez C. Principal findings of systematic reviews of acute asthma treatment in childhood. J Asthma 2015; 52:1038.</a></li><li><a class="nounderline abstract_t">Rodrigo GJ, Castro-Rodriguez JA. Heliox-driven β2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014; 112:29.</a></li><li><a class="nounderline abstract_t">Ballestero Y, De Pedro J, Portillo N, et al. Pilot Clinical Trial of High-Flow Oxygen Therapy in Children with Asthma in the Emergency Service. J Pediatr 2018; 194:204.</a></li><li><a class="nounderline abstract_t">Ni YN, Luo J, Yu H, et al. Can High-flow Nasal Cannula Reduce the Rate of Endotracheal Intubation in Adult Patients With Acute Respiratory Failure Compared With Conventional Oxygen Therapy and Noninvasive Positive Pressure Ventilation?: A Systematic Review and Meta-analysis. Chest 2017; 151:764.</a></li><li><a class="nounderline abstract_t">Wing R, James C, Maranda LS, Armsby CC. Use of high-flow nasal cannula support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency. Pediatr Emerg Care 2012; 28:1117.</a></li><li><a class="nounderline abstract_t">Godwin HT, Fix ML, Baker O, et al. Emergency Department Airway Management for Status Asthmaticus With Respiratory Failure. Respir Care 2020; 65:1904.</a></li><li><a class="nounderline abstract_t">McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003; 168:740.</a></li><li><a class="nounderline abstract_t">Davis DP, Hwang JQ, Dunford JV. Rate of decline in oxygen saturation at various pulse oximetry values with prehospital rapid sequence intubation. Prehosp Emerg Care 2008; 12:46.</a></li><li><a class="nounderline abstract_t">Kashiouris MG, Chou CD, Sedhai YR, et al. Endotracheal Tube Size Is Associated With Mortality in Patients With Status Asthmaticus. Respir Care 2022; 67:283.</a></li><li><a class="nounderline abstract_t">Binsaeedu AS, Prabakar D, Ashkar M, et al. Evaluating the Safety and Efficacy of Ketamine as a Bronchodilator in Pediatric Patients With Acute Asthma Exacerbation: A Review. Cureus 2023; 15:e40789.</a></li><li><a class="nounderline abstract_t">Hemmingsen C, Nielsen PK, Odorico J. Ketamine in the treatment of bronchospasm during mechanical ventilation. Am J Emerg Med 1994; 12:417.</a></li><li><a class="nounderline abstract_t">Petrillo TM, Fortenberry JD, Linzer JF, Simon HK. Emergency department use of ketamine in pediatric status asthmaticus. J Asthma 2001; 38:657.</a></li><li><a class="nounderline abstract_t">L'Hommedieu CS, Arens JJ. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med 1987; 16:568.</a></li><li><a class="nounderline abstract_t">Corssen G, Gutierrez J, Reves JG, Huber FC Jr. Ketamine in the anesthetic management of asthmatic patients. Anesth Analg 1972; 51:588.</a></li><li><a class="nounderline abstract_t">Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database Syst Rev 2012; 11:CD009293.</a></li><li><a class="nounderline abstract_t">Howton JC, Rose J, Duffy S, et al. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med 1996; 27:170.</a></li><li><a class="nounderline abstract_t">Nedel W, Costa R, Mendez G, et al. Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial. Anaesthesiol Intensive Ther 2020; 52:215.</a></li><li><a class="nounderline abstract_t">Boriosi JP, Lasarev MR, Peters ME, et al. Anticholinergics and serious adverse events in pediatric procedural sedation: A report of the pediatric sedation research consortiums. Paediatr Anaesth 2022; 32:665.</a></li><li><a class="nounderline abstract_t">Green SM, Roback MG, Krauss B, Emergency Department Ketamine Meta-analysis Study Group. Anticholinergics and ketamine sedation in children: a secondary analysis of atropine versus glycopyrrolate. Acad Emerg Med 2010; 17:157.</a></li><li class="breakAll">Zaloga GP, Todd M, Levit P, Marik P. Propofol-induced bronchodilation in patients with status asthmaticus. The Internet Journal of Emergency and Intensive Care Medicine, 2001; 5:1. http://www.ispub.com/journal/the-internet-journal-of-emergency-and-intensive-care-medicine/volume-5-number-1/propofol-induced-bronchodilation-in-patients-with-status-asthmaticus-1.html (Accessed on October 11, 2012).</li><li><a class="nounderline abstract_t">Conti G, Ferretti A, Tellan G, et al. Propofol induces bronchodilation in a patient mechanically ventilated for status asthmaticus. Intensive Care Med 1993; 19:305.</a></li><li><a class="nounderline abstract_t">Smischney NJ, Beach ML, Loftus RW, et al. Ketamine/propofol admixture (ketofol) is associated with improved hemodynamics as an induction agent: a randomized, controlled trial. J Trauma Acute Care Surg 2012; 73:94.</a></li><li><a class="nounderline abstract_t">Brenner B, Corbridge T, Kazzi A. Intubation and mechanical ventilation of the asthmatic patient in respiratory failure. J Emerg Med 2009; 37:S23.</a></li><li><a class="nounderline abstract_t">Chetana Shanmukhappa S, Kumar A, Dey A, et al. Omalizumab rescue therapy in refractory status asthmaticus. J Asthma 2023; 60:2243.</a></li><li><a class="nounderline abstract_t">Charles D, Shanley J, Temple SN, et al. Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta-analysis. Clin Exp Allergy 2022; 52:616.</a></li><li><a class="nounderline abstract_t">Lozano-Espinosa M, Antolín-Amérigo D, Riera J, et al. Extracorporeal membrane oxygenation (ECMO) and beyond in near fatal asthma: A comprehensive review. Respir Med 2023; 215:107246.</a></li><li><a class="nounderline abstract_t">Manasrah N, Abdelazeem B, Al Qasem S, et al. Extracorporeal Membrane Oxygenation (ECMO): A Life Saver in Near-Fatal Asthma. Cureus 2021; 13:e20117.</a></li><li><a class="nounderline abstract_t">Mikkelsen ME, Woo YJ, Sager JS, et al. Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus. ASAIO J 2009; 55:47.</a></li><li><a class="nounderline abstract_t">Zhai H, Huang L, Li T, et al. A successful extracorporeal cardiopulmonary resuscitation for severe status asthmaticus with an ultra-long cardiac arrest. Am J Emerg Med 2022; 62:145.e5.</a></li></ol></div><div id="topicVersionRevision">Topic 285 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34020637" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30362973" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : End tidal carbon dioxide monitoring in acute asthma: a prospective pilot study in emergency department patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32417445" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Asthma prolongs intubation in COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33217538" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Asthma in COVID-19 patients: An extra chain fitting around the neck?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33504226" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Asthma and COVID-19; different entities, same outcome: a meta-analysis of 107,983 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32663410" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28118145" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Noninvasive Ventilation For Patients In Acute Respiratory Distress: An Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26303207" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Principal findings of systematic reviews of acute asthma treatment in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24331390" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Heliox-drivenβ2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29331328" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pilot Clinical Trial of High-Flow Oxygen Therapy in Children with Asthma in the Emergency Service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28089816" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Can High-flow Nasal Cannula Reduce the Rate of Endotracheal Intubation in Adult Patients With Acute Respiratory Failure Compared With Conventional Oxygen Therapy and Noninvasive Positive Pressure Ventilation?: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114231" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Use of high-flow nasal cannula support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32723860" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Emergency Department Airway Management for Status Asthmaticus With Respiratory Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14522812" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Acute severe asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18189177" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Rate of decline in oxygen saturation at various pulse oximetry values with prehospital rapid sequence intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35190478" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Endotracheal Tube Size Is Associated With Mortality in Patients With Status Asthmaticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37485092" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Evaluating the Safety and Efficacy of Ketamine as a Bronchodilator in Pediatric Patients With Acute Asthma Exacerbation: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8031424" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ketamine in the treatment of bronchospasm during mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11758894" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Emergency department use of ketamine in pediatric status asthmaticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3565871" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The use of ketamine for the emergency intubation of patients with status asthmaticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5064793" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Ketamine in the anesthetic management of asthmatic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23152273" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Ketamine for management of acute exacerbations of asthma in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8629747" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32876408" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35072305" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Anticholinergics and serious adverse events in pediatric procedural sedation: A report of the pediatric sedation research consortiums.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20370745" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Anticholinergics and ketamine sedation in children: a secondary analysis of atropine versus glycopyrrolate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20370745" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Anticholinergics and ketamine sedation in children: a secondary analysis of atropine versus glycopyrrolate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8408944" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Propofol induces bronchodilation in a patient mechanically ventilated for status asthmaticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22743378" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Ketamine/propofol admixture (ketofol) is associated with improved hemodynamics as an induction agent: a randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19683662" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Intubation and mechanical ventilation of the asthmatic patient in respiratory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37427873" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Omalizumab rescue therapy in refractory status asthmaticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35174566" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37245648" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Extracorporeal membrane oxygenation (ECMO) and beyond in near fatal asthma: A comprehensive review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34984154" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Extracorporeal Membrane Oxygenation (ECMO): A Life Saver in Near-Fatal Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19092662" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36100495" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A successful extracorporeal cardiopulmonary resuscitation for severe status asthmaticus with an ultra-long cardiac arrest.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
